MC1317A1 - Derives de l'uree - Google Patents

Derives de l'uree

Info

Publication number
MC1317A1
MC1317A1 MC801437A MC1437A MC1317A1 MC 1317 A1 MC1317 A1 MC 1317A1 MC 801437 A MC801437 A MC 801437A MC 1437 A MC1437 A MC 1437A MC 1317 A1 MC1317 A1 MC 1317A1
Authority
MC
Monaco
Prior art keywords
isocyanatothiophene
formula
urea
thienyl
creatinine
Prior art date
Application number
MC801437A
Other languages
English (en)
French (fr)
Inventor
W Hunkeler
E Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1317A1 publication Critical patent/MC1317A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MC801437A 1979-03-14 1980-03-14 Derives de l'uree MC1317A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH241579 1979-03-14
CH17180 1980-01-10

Publications (1)

Publication Number Publication Date
MC1317A1 true MC1317A1 (fr) 1981-03-10

Family

ID=25683737

Family Applications (1)

Application Number Title Priority Date Filing Date
MC801437A MC1317A1 (fr) 1979-03-14 1980-03-14 Derives de l'uree

Country Status (10)

Country Link
EP (1) EP0016371A1 (enExample)
AU (1) AU5628380A (enExample)
DK (1) DK108780A (enExample)
ES (1) ES8103737A1 (enExample)
FI (1) FI800559A7 (enExample)
GR (1) GR66630B (enExample)
IL (1) IL59563A0 (enExample)
MC (1) MC1317A1 (enExample)
NO (1) NO800720L (enExample)
PT (1) PT70949B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
PT1580188E (pt) 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
RS52625B (sr) 2003-07-23 2013-06-28 Bayer Healthcare Llc Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
ATE517885T1 (de) 2004-04-30 2011-08-15 Bayer Healthcare Llc Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448869A1 (de) * 1973-10-19 1975-09-04 Mcneilab Inc 4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas
US4025517A (en) * 1975-06-23 1977-05-24 Mcneil Laboratories, Incorporated 4-Oxo-2-hexahydropyrimidinylidene ureas

Also Published As

Publication number Publication date
PT70949A (en) 1980-04-01
FI800559A7 (fi) 1981-01-01
ES489493A0 (es) 1981-03-16
IL59563A0 (en) 1980-06-30
AU5628380A (en) 1980-09-18
GR66630B (enExample) 1981-04-03
DK108780A (da) 1980-09-15
ES8103737A1 (es) 1981-03-16
PT70949B (en) 1981-06-24
EP0016371A1 (de) 1980-10-01
NO800720L (no) 1980-09-15

Similar Documents

Publication Publication Date Title
MC1317A1 (fr) Derives de l'uree
CH657359A5 (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutique les contenant.
FR2488605A1 (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
CA2152184A1 (fr) Derives de thiazolidine, leur preparation et les medicaments les contenant
MC1618A1 (fr) Steroides
FR2515179A1 (fr) Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
BE898383A (fr) Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique.
MC1156A1 (fr) Composes cycliques
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
MC1984A1 (fr) Derives de la purine
MC1919A1 (fr) Derives de l'imidazole
EP0520016A1 (fr) Derives de l'uree, leur preparation et les medicaments les contenant.
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
EP0179076B1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
MC1287A1 (fr) Derives de cyclohexadiene
MC1568A1 (fr) Derives de benzamide
MC1169A1 (fr) Composes tricycliques
EP0300850B1 (fr) Dérivés de 1-arylsulfonyl 1,5-dihydro 2H-pyrrol-2-one, leurs procédé et intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
EP0294295B1 (fr) Dérivés de la 1-arylsulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
FR2458552A1 (fr) Nouveaux alcaloides peptidiques de l'ergot de seigle, leur preparation et leur application comme medicaments
BE897763A (fr) Sel de l'acide piperidinyl-cyclopentanol heptenoique
MC2052A1 (fr) Derives de l'imidazodiazepine
FR2548180A1 (fr) Amides d'acides carboxyliques et leurs derives, leur preparation et leur application en therapeutique
FR2480602A1 (fr) Hexahydro-pyrimido(1,2-a)azepines 3-substituees a titre de medicaments
EP0005422A2 (fr) Dérivés d'acides oméga-dialkylalkanoiques, leurs procédés de préparation ainsi que leur utilisation en thérapeutique

Legal Events

Date Code Title Description
YP Annual fee paid